Medicenna TherapeuticsMDNAF
13F holders, Q4 2024 (December 31)1holders
0new positions
0sold out
$1.15avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Medicenna Therapeutics Corp. (MDNAF) in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holder was ORG Partners LLC ($200K).
- Company
- Medicenna Therapeutics Corp.
- CUSIP
- 58490H107
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 50,000 shares bought, net +50,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| ORG Partners LLC | 0.03% | Add +40.0% | 175,000 | $200K |
"% of holder's portfolio" is MDNAF's weight in each manager's 13F, not the share of Medicenna Therapeutics Corp. the manager owns.